NPC(600713)2024-10-30 07:35Financial Performance - The company's operating revenue for Q3 2024 was ¥13,706,070,292.09, representing a year-on-year increase of 3.81%[4] - The net profit attributable to shareholders for the same period was ¥130,561,167.10, showing a slight decrease of 0.83% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was ¥131,011,754.58, down by 1.87% year-on-year[4] - Total revenue for the first three quarters of 2024 reached CNY 40,938,180,822.52, a slight increase of 0.97% compared to CNY 40,546,782,609.42 in the same period of 2023[23] - The total operating profit for Q3 2024 was approximately CNY 771.61 million, an increase from CNY 754.69 million in Q3 2023, representing a growth of 2.4%[24] - The net profit attributable to shareholders of the parent company reached CNY 441.88 million, slightly up from CNY 440.30 million in the same period last year, indicating a marginal increase of 0.4%[24] - The total comprehensive income for Q3 2024 was CNY 591.96 million, compared to CNY 537.99 million in Q3 2023, reflecting a growth of 10.0%[24] - Net profit for the first three quarters of 2024 was CNY 365,157,231.84, compared to CNY 361,146,861.02 in 2023, reflecting an increase of 1.1%[30] Assets and Liabilities - The total assets at the end of the reporting period reached ¥32,454,107,239.26, an increase of 14.23% compared to the end of the previous year[4] - The equity attributable to shareholders was ¥6,712,269,732.43, reflecting a year-on-year increase of 4.31%[4] - Total liabilities increased to CNY 24,907,810,851.99, up from CNY 21,155,305,375.35, representing a growth of 12.99%[22] - The company's total assets reached CNY 32,454,107,239.26, compared to CNY 28,410,231,716.06 in the previous year, marking an increase of 14.39%[22] - The company's total liabilities increased to CNY 13,318,867,113.11 from CNY 10,888,031,729.77, reflecting a growth of 22.3%[28] - The company reported a significant increase in long-term liabilities, which rose to CNY 5,178,146,355.71 from CNY 2,589,271,824.62, an increase of 99.00%[22] Cash Flow - The company reported a net cash flow from operating activities of -¥2,893,831,769.59 for the year-to-date period[4] - Cash flow from operating activities showed a net outflow of CNY 2.89 billion, an improvement from a net outflow of CNY 4.48 billion in the previous year, indicating a reduction in cash burn[25] - The company's cash and cash equivalents decreased significantly to CNY 1,159,037,620.22 from CNY 2,371,578,790.60, a decline of 51.16%[21] - The cash received from sales of goods and services was CNY 9,659,968,000.25, down from CNY 11,119,002,324.16 in the previous year, a decline of 13.1%[31] - The net cash flow from financing activities was 3,366,404,174.11 in the previous period[32] Shareholder Information - The top shareholder, Nanjing New Industry Investment Group Co., Ltd., holds 44.16% of the shares, totaling 578,207,286 shares[6] Investments and Projects - The company is involved in the construction of the Fujian Tongchun Biopharmaceutical Industrial Park, with part of the main structure completed[16] - The company has invested CNY 331.35 million in purchasing office space for its headquarters, with a total area of 27,612.40 m²[17] - The company plans to publicly dispose of assets from its subsidiary, with an estimated value of CNY 37.35 million[18] - The company has a research and development budget of CNY 30.62 million for several collaborative projects with its controlling shareholder[15] - Research and development expenses for the first three quarters were CNY 30,536,340.65, up from CNY 28,507,614.74, indicating an increase of 7.09%[23] - Research and development expenses for the first three quarters of 2024 were CNY 8,818,792.19, up from CNY 6,771,698.11 in 2023, indicating a growth of 30.2%[29] Future Outlook - The company plans to focus on expanding its market presence and enhancing its product offerings in the upcoming quarters[26] - The company has invested significantly in new technologies and product development to drive future growth[26] - The management remains optimistic about achieving better financial performance in the next quarter, supported by strategic initiatives and market expansion efforts[26] Accounting and Reporting - The company has adopted new accounting standards starting in 2024, which may affect financial reporting[33] - The report was published on October 31, 2024, indicating the company's commitment to timely financial disclosures[33]